Department of Pharmacy, School of Pharmaceutical Sciences, University of São Paulo, São Paulo, 05508-000, Brazil.
International Journal of Science and Research Archive, 2024, 13(01), 1232–1239.
Article DOI: 10.30574/ijsra.2024.13.1.1807
DOI url: https://doi.org/10.30574/ijsra.2024.13.1.1807
Received on 10 August 2024; revised on 23 September 2024; accepted on 25 September 2024
Nitazoxanide (NTZ) is a broad-spectrum antiparasitic drug with low bioavailability due to its poor aqueous solubility, classified as a Biopharmaceutical Classification System (BCS) class II drug. This study aimed to improve the understanding of NTZ nanocrystalline suspensions produced via the solvent-antisolvent technique. NTZ was extracted from commercially available coated tablets and characterized using DSC, TG, UV-Vis, and FTIR, revealing the presence of impurities likely from excipients. Nanocrystalline suspensions were prepared using three different stabilizers (Lecithin, Poloxamer 188, and Tween® 80) and evaluated for particle size distribution (PSD) and polydispersity index (PDI) over a one-week stability study. Poloxamer 188 was the most effective in reducing particle size (934.7 nm), though Lecithin achieved a more favorable PDI (0.289), indicating better particle uniformity. These findings suggest the solvent-antisolvent technique is a promising approach for producing NTZ nanocrystalline suspensions, but further reduction in particle size and exploration of alternative stabilizers are needed to optimize stability and performance.
Nitazoxanide; Nanocrystalline suspension; Solven-antisolvent; Bottom-up; Nanoparticles; Pharmaceutical Technology
Preview Article PDF
Rui Filipe da Conceição Teixeira, Lucas Antunes Araújo and Gabriel Lima Barros de Araújo. Exploratory study on physicochemical properties of nitazoxanide nanocrystalline suspension obtained by evaporative solvent-antisolvent technique. International Journal of Science and Research Archive, 2024, 13(01), 1232–1239. https://doi.org/10.30574/ijsra.2024.13.1.1807






